Lan Shen

958 total citations
38 papers, 638 citations indexed

About

Lan Shen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Lan Shen has authored 38 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cancer Research. Recurrent topics in Lan Shen's work include Cardiac Imaging and Diagnostics (4 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Lan Shen is often cited by papers focused on Cardiac Imaging and Diagnostics (4 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Lan Shen collaborates with scholars based in China, United States and France. Lan Shen's co-authors include Chunxiao Yan, Xuejun Chen, Jianhua Yang, Ancai Yuan, Jun Pu, Min Fang, Dawei Jiang, Min Cai, Xuefeng Wang and Jie Zhang and has published in prestigious journals such as Cancer Research, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Lan Shen

34 papers receiving 630 citations

Peers

Lan Shen
Zahida Qamri United States
Yang Qiu China
Yan Long China
Pan Gao China
Zahida Qamri United States
Lan Shen
Citations per year, relative to Lan Shen Lan Shen (= 1×) peers Zahida Qamri

Countries citing papers authored by Lan Shen

Since Specialization
Citations

This map shows the geographic impact of Lan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shen more than expected).

Fields of papers citing papers by Lan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shen. The network helps show where Lan Shen may publish in the future.

Co-authorship network of co-authors of Lan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Shen. A scholar is included among the top collaborators of Lan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Shen. Lan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Lan, Ying Liao, Lei Tan, et al.. (2025). Oncolytic Newcastle disease virus promotes tumor cell death via the anoikis effector Bit1 translocation. Virologica Sinica. 40(5). 842–852.
3.
Huo, Huanhuan, et al.. (2023). Role of Pericytes in Cardiomyopathy-Associated Myocardial Infarction Revealed by Multiple Single-Cell Sequencing Analysis. Biomedicines. 11(11). 2896–2896. 1 indexed citations
4.
Jiang, Lisheng, Ke Xu, Lan Shen, et al.. (2023). Left atrial appendage angiography for stroke risk prediction in patients with atrial fibrillation. EuroIntervention. 19(8). 695–702. 2 indexed citations
5.
Jiang, Kai, Feng Chen, Jie Qian, et al.. (2022). Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia. Biomedicine & Pharmacotherapy. 154. 113606–113606. 14 indexed citations
6.
Yu, Yongfeng, Jie Qian, Lan Shen, Wenxiang Ji, & Shun Lü. (2022). Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologists. Annals of Translational Medicine. 10(2). 41–41. 2 indexed citations
7.
Zhang, Yipeng, Lan Shen, Wentao Yang, & Ben He. (2021). Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 679703–679703. 4 indexed citations
8.
Shen, Lan, et al.. (2021). Bioinformatic Analysis of Crosstalk Between circRNA, miRNA, and Target Gene Network in NAFLD. Frontiers in Genetics. 12. 671523–671523. 7 indexed citations
9.
Yu, Yongfeng, Jie Qian, Lan Shen, Wenxiang Ji, & Shun Lü. (2021). Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing. International Journal of Medical Sciences. 18(6). 1510–1518. 14 indexed citations
10.
Shen, Lan, et al.. (2021). 7-Ethoxyrosmanol alleviates hyperglycemia-induced vascular endothelial dysfunction by regulating FBXL7 expression. Journal of Bioenergetics and Biomembranes. 53(5). 553–560. 3 indexed citations
11.
Li, Yanjie, Yinghua Wang, Zi Wang, et al.. (2020). Salvianolic Acid B Improves Postresuscitation Myocardial and Cerebral Outcomes in a Murine Model of Cardiac Arrest: Involvement of Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 17 indexed citations
12.
Jiang, Dawei, et al.. (2019). Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer. Cancer Cell International. 19(1). 47–47. 53 indexed citations
13.
Shen, Lan, Liu Xu, Jie Zhang, & Dawei Jiang. (2018). Preoperative Serum Insulin-Like Growth Factor 1 Level as a Prognostic Factor in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. Journal of Interferon & Cytokine Research. 38(4). 153–160. 3 indexed citations
14.
Jiang, Lisheng, Min Zhang, Hong Zhang, et al.. (2018). A potential protective element of myocardial bridge against severe obstructive atherosclerosis in the whole coronary system. BMC Cardiovascular Disorders. 18(1). 105–105. 12 indexed citations
15.
Chen, Dan, Wang Zh, Chunlei Zhou, et al.. (2014). Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. Journal of Molecular Neuroscience. 54(1). 1–9. 18 indexed citations
16.
Shen, Lan, Ziming Li, Shengping Shen, et al.. (2012). The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. Lung Cancer. 78(3). 193–200. 27 indexed citations
17.
Fang, Min, Lan Shen, Huan Yin, et al.. (2011). Downregulation of gephyrin in temporal lobe epilepsy neurons in humans and a rat model. Synapse. 65(10). 1006–1014. 27 indexed citations
18.
Liu, Guangwei, et al.. (2010). Abnormal expression of netrin-G2 in temporal lobe epilepsy neurons in humans and a rat model. Experimental Neurology. 224(2). 340–346. 33 indexed citations
19.
Xiao, Zheng, Lan Shen, Dan Chen, et al.. (2010). Talin 2 concentrations in cerebrospinal fluid in patients with epilepsy. Clinical Biochemistry. 43(13-14). 1129–1132. 6 indexed citations
20.
Shan, Peiren, et al.. (2008). RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochemical and Biophysical Research Communications. 375(4). 628–633. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026